Aethlon claims 50% blood serum clearance of Zika virus in 5 hours

Aethlon Medical (OTC:AEMD) said today that data from in vitro Zika virus studies of its Hemopurifier blood filter indicated a 50% clearance of the virus from human blood serum in 5 hours. The San Diego, Calif.-based company said the Zika studies, which were conducted with small-scale versions of the Hemopurifier, also reported a 95% clearance rate of the virus from cell culture fluid in 5.5 hours. “As a result of our research team’s validation of Zika capture, we have further reinforced the potential of our Hemopurifier to be a 1st line of defense against the growing list of infectious viral pathogens that are not addressed with traditional drug or vaccine therapies,” CEO Jim Joyces aid in a press release. The Zika studies were conducted on a viral strain that has recently spread from South America to Peurto Rico, the company said. Aethlon Medical also said it inked an agreement with the Devense Advanced Research Projects Agency to study the in vitro capture of Middle East Respiratory Syndrome Coronavirus. The agreement is based on the modification of a contract milestone that is part of DARPA’s Dialysis-Like therapeutics program, the company said. Last September, Aethlon said it extended its contract with DARPA to develop a device to reduce the incidence of sepsis, a commonly fatal infection encountered by combat-injured soldiers. The contract with DARPA was originally inked in September 2011 and has been extended to its 5th year with A...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Blood Management Clinical Trials Aethlon Medical Inc. Source Type: news

Related Links:

(CNN) — From climate change to superbugs, the World Health Organization has laid out 10 big threats to our global health in 2019. And unless these threats get addressed, millions of lives will be in jeopardy. Here’s a snapshot of 10 urgent health issues, according to the United Nations’ public health agency: Not vaccinating when you can One of the most controversial recent health topics in the US is now an international concern. “Vaccine hesitancy — the reluctance or refusal to vaccinate despite the availability of vaccines — threatens to reverse progress made in tackling vaccine-prevent...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News CNN Local TV Source Type: news
Abstract Recently, human infections with severe fever with thrombocytopenia syndrome virus (SFTSV) leading to fatality, have dramatically increased in East Asia. With the unavailability of vaccines or antiviral drugs to prevent and/or treat SFTSV infection, early rapid diagnosis is critical for prevention and control of the disease. Here, we report the development of a simple, rapid and sensitive portable detection method for SFTSV infection applying reverse transcription-loop mediated isothermal amplification (RT-LAMP) combined with one-pot colorimetric visualization and electro-free reaction platform. This metho...
Source: Journal of Microbiology and Biotechnology - Category: Biotechnology Authors: Tags: J Microbiol Biotechnol Source Type: research
In this study, an arch-shaped amplification containing primer sequences was designed to rapidly amplify multiple targets. Further, the sensing platform allowed for sensitive and specific detection of human coronavirus, Middle East respiratory syndrome, Zika virus, and Ebola virus down to several copies. This platform also simultaneously distinguished between Middle East respiratory syndrome and human coronavirus in clinical specimens within 20 min. This arch-shaped multiple-target sensing assay can provide rapid, sensitive, and accurate diagnoses of emerging infectious diseases in clinical applications.
Source: Biosensors and Bioelectronics - Category: Biotechnology Source Type: research
CONCLUSION: Compounds V and VI were demonstrated viral inhibition towards Human cytomegalovirus, whereas cyclopropylquinoline derivative IV towards Rift Valley fever virus and Tacaribe virus. Additionally, cyclopropylquinoline derivative IV has displayed very good cytotoxicity against colon, breast and leukemia cell lines in vitro. PMID: 29792154 [PubMed - as supplied by publisher]
Source: Medicinal Chemistry - Category: Chemistry Authors: Tags: Med Chem Source Type: research
World Health Organization. 02/08/2018 This Web page provides the 2018 List of Priority Diseases, which include Ebola virus disease and Marburg virus disease, Lassa fever, Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS), and Zika virus. Experts consider that given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated research and development for these diseases. (Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Authors: Source Type: news
AbstractIn recent years, unexpected outbreaks of infectious diseases caused by emerging and re-emerging viruses have become more frequent, which is possibly due to environmental changes. These outbreaks result in the loss of life and economic hardship. Vaccines and therapeutics should be developed for the prevention and treatment of infectious diseases. In this review, we summarize and discuss the latest progress in the development of small-molecule viral inhibitors against highly pathogenic coronaviruses, including severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, Ebola virus,...
Source: Frontiers of Medicine - Category: General Medicine Source Type: research
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Source Type: research
In September, 2017, up to 2 million pilgrims from all continents will arrive in Saudi Arabia for the annual Hajj pilgrimage.1 Living and worshipping together in crowded conditions will expose the pilgrims and the local Saudi Arabian community to a range of imported and local infections.1 Over the past 5 years the Hajj has focused attention on new and re-emerging infectious diseases with epidemic potential such as the Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus, and pan-antibiotic-resistant bacteria —global health security threats that are ongoing and under active surveillance.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Comment Source Type: research
Conclusions: Bio-innovators are enthusiastically creating POC technologies in Taiwan, including low marginal cost assay modules capable of transforming public health paradigms. Geospatial analysis showed that POCT can speed acute response in rural areas of Hualien County. At a national convocation of the Taiwan Association of Medical Technologists, P&G receptivity and support were strong, suggesting Taiwan will publish national POCT P&G. Priorities include rural areas and vulnerable populations.
Source: Point of Care: The Journal of Near-Patient Testing and Technology - Category: Pathology Tags: Original Articles Source Type: research
National Institutes of Health. 05/16/2017 This one-hour, 25-minute presentation discusses infectious disease challenges in 2017: established infectious diseases, newly emerging diseases, and re-emerging diseases. It provides examples of established infectious diseases of global health importance, and global examples of newly emerging and re-emerging infectious diseases, including chikungunya, dengue, and Middle East respiratory syndrome coronavirus (MERS-CoV). It includes a detailed discussion of the Zika virus, yellow fever, Ebola, and pandemic influenza. (Video or Multimedia)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Authors: Source Type: news
More News: Clinical Trials | Contracts | Coronavirus | Dialysis | Medical Devices | MERS | Middle East Health | Respiratory Medicine | Study | Vaccines | Zika Virus